Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
Vaccine
; 40(34): 5050-5059, 2022 08 12.
Article
in En
| MEDLINE
| ID: mdl-35868948
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
4_TD
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Oceania
Language:
En
Journal:
Vaccine
Year:
2022
Document type:
Article